1. Park S, Lim W, Bazer FW, Song G. Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis cells. Mol Hum Reprod 2017; 23:842-854.
2. Davoodi Asl F, Sahraei SS, Kalhor N, Fazaeli H, Sheykhhasan M, Soleimani Moud S, et al. Promising effects of exosomes from menstrual blood-derived mesenchymal stem cells on endometriosis. Reprod Biol 2023; 23:100788.
3. Vercellini P, Crosignani P, Somigliana E, Vigano P, Frattaruolo MP, Fedele L. ‘Waiting for Godot’: A commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26:3-13.
4. Hung SW, Zhang R, Tan Z, Chung JPW, Zhang T, Wang CC. Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review. Med Res Rev 2021; 41:2489-2564.
5. Bozdag G. Recurrence of endometriosis: Risk factors, mechanisms and biomarkers. Womens Health (Lond) 2015; 11:693-699.
6. Sampson JA. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940; 40:549-557.
7. Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014; 2014:179515-179523.
8. Laschke MW, Menger MD. Basic mechanisms of vascularization in endometriosis and their clinical implications. Hum Reprod Update 2018; 24:207-224.
9. Sahraei SS, Kowsari A, Asl FD, Sheykhhasan M, Naserpoor L, Sheikholeslami A. Evaluating the effect of conditioned medium from endometrial stem cells on endometriosis-derived endometrial stem cells. Anat Cell Biol 2022; 55:100-108.
10. Sahraei SS, Davoodi Asl F, Kalhor N, Sheykhhasan M, Fazaeli H, Moud SS, et al. A comparative study of gene expression in
menstrual blood-derived stromal cells between endometriosis and
healthy women. Biomed Res Int 2022; 2022:7053521-7053531.
11. Sheikholeslami A, Kalhor N, Sheykhhasan M, Jannatifar R, Sahraei SS. Evaluating differentiation potential of the human menstrual blood-derived stem cells from infertile women into oocyte-like cells. Reprod Biol 2021; 21:100477.
12.Park S, Lim W, Bazer FW, Song G. Apigenin induces ROS‐dependent apoptosis and ER stress in human endometriosis cells. J Cell Physiol 2018; 233:3055-3065.
13. Hirakawa T, Nasu K, Miyabe S, Kouji H, Katoh A, Uemura N, et al. beta-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis. Sci Rep 2019; 9:20056-20066.
14.Xiong W, Zhang L, Liu H, Li N, Du Y, He H, et al. E(2) -mediated EMT by activation of β-catenin/Snail signalling during the development of ovarian endometriosis. J Cell Mol Med 2019; 23:8035-8045.
15. Matsuzaki S, Botchorishvili R, Pouly JL, Canis M. Targeting the Wnt/β-catenin pathway in endometriosis: A potentially effective approach for treatment and prevention. Mol Cell Ther 2014; 2:1-7.
16. Matsuzaki S, Darcha C. Involvement of the Wnt/β-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One 2013; 8:e76808.
17. Zheng Y, Khan Z, Zanfagnin V, Correa LF, Delaney AA, Daftary GS. Epigenetic modulation of collagen 1A1: Therapeutic implications in fibrosis and endometriosis. Biol Reprod 2016; 94:1-10.
18. Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, et al. Safety, tolerability, and preliminary efficacy of the antifibrotic small molecule PRI-724, a CBP/β-catenin inhibitor, in
patients with hepatitis C virus-related cirrhosis: A single-center, open-label, dose escalation phase 1 trial. EBioMedicine 2017; 23:79-87.
19. Martinez-Font E, Perez-Capo M, Ramos R, Felipe I, Garcias C, Luna P, et al. Impact of Wnt/beta-catenin inhibition on cell proliferation through CDC25A downregulation in soft tissue sarcomas. Cancers (Basel) 2020; 12:2556-2575.
20. Makker A, Goel MM, Das V, Agarwal A. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: An update. Gynecol Endocrinol 2012; 28:175-181.
21. Yin X, Pavone ME, Lu Z, Wei J, Kim JJ. Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis. J Clin Endocrinol Metab 2012; 97:E35-E43.
22. Matsuzaki S, Darcha C. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro. Hum Reprod 2015; 30:1606-1616.
23. Ma T, Liu P, Wei J, Zhao M, Yao X, Luo X, et al. Imperatorin alleviated endometriosis by inhibiting the activation of PI3K/Akt/NF-κB pathway in rats. Life Sci 2021; 274:119291.
24. Eaton JL, Unno K, Caraveo M, Lu Z, Kim JJ. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis. J Clin Endocrinol Metab 2013; 98:E1871-1879.
25. Leconte M, Nicco C, Ngo C, Arkwright S, Chereau C, Guibourdenche J, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010; 177:2963-2970.
26.Bodet C, La VD, Epifano F, Grenier D. Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. J Periodontal Res 2008; 43:400-407.
27. Sarojamma V, Vadde R. Naringenin in the prevention of colon
cancer: An updated review. Onco Therapeutics 2022; 9.
28. Galluzzo P, Ascenzi P, Bulzomi P, Marino M. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 2008; 149:2567-2575.
29. Davoodi Asl F, Sahraei SS, Kalhor N, Fazaeli H, Sheykhhasan M, Soleimani Moud S, et al. Promising effects of exosomes from menstrual blood-derived mesenchymal stem cells on endometriosis. Reprod Biol 2023; 23:100788.
30. Hirakawa T, Nasu K, Miyabe S, Kouji H, Katoh A, Uemura N, et al. β-catenin signaling inhibitors ICG-001 and C-82 improve fibrosis in preclinical models of endometriosis. Sci Rep 2019; 9:20056.
31. Velarde MC, Aghajanova L, Nezhat CR, Giudice LC. Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3’,5’-cyclic adenosine 5’-monophosphate inhibition of cyclin D1. Endocrinology 2009; 150:4701-4712.
32. Szondy Z, Sarang Z, Kiss B, Garabuczi É, Köröskényi K. Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance. Front Immunol 2017; 8:909-918.
33. Poon IKH, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17:381-397.
34. Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, Ishikawa M. Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 2006; 166:131-139.
35. Zuo XL, Zhou Y, Li RF, Feng YQ, He L, Liu MH. [Relation of
apoptosis of K562 cells induced by naringenin in vitro to enzyme
activity changes of caspase-3 and caspase-8 and expression of FAS/FASL proteins]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16:286-289.
36. Ngô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol 2009; 175:225-234.
37. Rani N, Bharti S, Krishnamurthy B, Bhatia J, Sharma C, Kamal MA, et al. Pharmacological properties and therapeutic potential of naringenin: A citrus flavonoid of pharmaceutical promise. Curr Pharm Des 2016; 22:4341-4359.
38. Edmunds KM, Holloway AC, Crankshaw DJ, Agarwal SK, Foster WG. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod Nutr Dev 2005; 45:709-720.
39. Rashmi R, Bojan Magesh S, Mohanram Ramkumar K, Suryanarayanan S, Venkata SubbaRao M. Anti-oxidant potential of naringenin helps to protect liver tissue from streptozotocin-induced damage. Rep Biochem Mol Biol 2018; 7:76-84.
40. Germeyer A, Jauckus J, Zorn M, Toth B, Capp E, Strowitzki T. Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reprod Biomed Online 2011; 22:327-334.
41. Li S, Fu X, Wu T, Yang L, Hu C, Wu R. Role of interleukin-6 and its receptor in endometriosis. Med Sci Monit 2017; 23:3801-3807.
42. Matsuzaki S, Botchorishvili R, Pouly JL, Canis M. Targeting the Wnt/β-catenin pathway in endometriosis: A potentially effective approach for treatment and prevention. Mol Cell Ther 2014; 2:36-42.
43. Sutrisno S, Nooryanto M, Gani SW. Comparison of pain intensity, smooth muscle cells density, and alpha-smooth muscle actin expression in ovarian and peritoneal endometriosis. J Obstet Gynecol Sci 2021; 29:108-117.
44. Miró J, Gutiérrez-Reinoso M, da Silva JA, Fernandes C, Rebordão MR, Alexandre-Pires G, et al. Collagen and eosinophils in jenny’s endometrium: Do they differ with endometrial classification? Front Vet Sci 2020; 7:631-640.
45. Zheng Y, Khan Z, Zanfagnin V, Correa LF, Delaney AA, Daftary GS. Epigenetic modulation of collagen 1a1: therapeutic implications in fibrosis and endometriosis1. Biol Reprod 2016; 94: 87-96.
46. Lessey BA, Palomino WA, Apparao KB, Young SL, Lininger RA. Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol 2006; 4 Suppl 1:S9-S18.
47. Shebley M, Polepally AR, Nader A, Ng JW, Winzenborg I, Klein CE, et al. Clinical pharmacology of elagolix: An oral gonadotropinreleasing hormone receptor antagonist for endometriosis. Clin Pharmacokinet 2020; 59:297-309.
48. Yalcin SE, Ocal I, Yalcin Y, Selim HS, Caltekin MD, Aydogmus H, et al. Evaluation of the Ki-67 proliferation index and urocortin
expression in women with ovarian endometriomas. Eurasian J Med 2017; 49:107-112.
49. Jiang P, Jia M, Hu J, Huang Z, Deng Y, Lai L, et al. Prognostic value of Ki67 in patients with stage 1-2 endometrial cancer: Validation of the cut-off value of Ki67 as a predictive factor. Onco Targets Ther 2020; 13:10841-10850.
50. Luo J, Song Z, Zhang T, Chu K, Li J, Zhou J, et al. Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis. J Zhejiang Univ Sci B 2022; 23:158-163.
51. Gallo D, Zannoni GF, Fabrizi M, De Stefano I, Mantuano E, Scambia G. Comparative effects of 17β-estradiol and phytoestrogens in the regulation of endometrial functions in the rodent uterus. J Endocrinol Invest 2008; 31:48-56.
52. Takaoka O, Mori T, Ito F, Okimura H, Kataoka H, Tanaka Y, et al. Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis. J Steroid Biochem Mol Biol 2018; 181:125-132.
)